← Back to catalogue

ETEST Gepotidacin (GEP) (0.016-256 µg/mL)

FDA 510(k)EUDAMED

Class II (US FDA 510(k))

510(k) K260447Ref 543240Ref 543064

by Biomerieux Sa

Identity

Trade Name
ETEST® Gepotidacin (GEP) EUDAMED
Device Name
ETEST® Gepotidacin (GEP) EUDAMED
Model / Reference
543240 EUDAMED
543064 EUDAMED

Identifiers

Primary DI / UDI-DI
03573026630607 EUDAMED
03573026625252 EUDAMED
Basic UDI-DI
357302BUDI002230TB EUDAMED
357302BUDI002136TJ EUDAMED
Unit of Use DI
03573026630591 EUDAMED
510(k) Number
K260447 FDA 510(k)
FDA Product Code
JWY FDA 510(k)
EMDN Code
W0104080501 MIC SYSTEMS - DILUTION METHODS (INCL. E-TEST) EUDAMED

Classification

Device Class
Class B EUDAMED
Class II FDA 510(k)
Legislation / Framework
21 CFR Part 866.1640 FDA 510(k)
Regulation Number
866.1640 FDA 510(k)
Market of Registration
France EUDAMED
Advisory Committee
Microbiology FDA 510(k)
FDA Decision
SESE Substantially Equivalent FDA 510(k)

Clinical & Handling

Sterile

No

EUDAMED

Human Tissues

No

EUDAMED

Animal Tissues

No

EUDAMED

Microbial Substances

No

EUDAMED

Reagent

Yes

EUDAMED

Self Testing

No

EUDAMED

Near-Patient Testing

No

EUDAMED

Professional Testing

Yes

EUDAMED

Companion Diagnostics

No

EUDAMED

Surgical Instrument

No

EUDAMED

New Device

No

EUDAMED

The ETEST Gepotidacin (GEP) is a manual antimicrobial susceptibility test system designed for determining bacterial susceptibility to gepotidacin. It falls under the category of Manual Antimicrobial Susceptibility Test Systems, utilising an inert plastic strip with a predefined exponential antibiotic gradient (0.016–256 µg/mL) to assess microbial resistance or susceptibility in vitro.

This device is used in microbiology laboratories to test bacterial isolates from clinical samples by applying the strip to an inoculated agar surface. The antibiotic diffuses into the agar, creating a stable gradient that inhibits bacterial growth, forming a measurable inhibition ellipse. Supplied as a single-use system, it adheres to IVDR and FDA 510(k) clearance (K260447) under Substantial Equivalence determination, with regulatory classification as a Class II device (866.1640). Limited testing data for Staphylococcus saprophyticus resistance detection is noted in the submission.

Frequently asked questions

How does the ETEST Gepotidacin system determine if a bacterial isolate is resistant or susceptible to gepotidacin?

The ETEST Gepotidacin system uses an inert plastic strip with a built-in gradient of gepotidacin concentrations (ranging from 0.016 to 256 µg/mL). When applied to an inoculated agar surface, the antibiotic diffuses outward, creating a concentration gradient. Bacterial growth is inhibited where the antibiotic concentration exceeds the organism’s resistance threshold, forming an elliptical zone. The size and shape of this inhibition ellipse are measured to determine whether the isolate is susceptible or resistant to gepotidacin, following standardized interpretation criteria.

Is the ETEST Gepotidacin strip designed for single-use only, and if so, why?

Yes, the ETEST Gepotidacin strip is intended for single-use only. This design choice ensures accuracy and reliability, as repeated use could compromise the integrity of the antibiotic gradient on the strip or introduce contamination. Single-use also aligns with best practices in microbiology testing to maintain consistency and prevent cross-contamination between samples.

What bacterial species is the ETEST Gepotidacin system primarily validated for, and are there any limitations mentioned in the data?

The ETEST Gepotidacin system is designed for determining bacterial susceptibility to gepotidacin in general microbiology laboratory settings. While the primary focus is on common bacterial isolates, the submission notes that testing data for *Staphylococcus saprophyticus* resistance detection is limited. Clinicians should verify local guidelines or consult the manufacturer’s instructions for specific species or clinical scenarios.

How is the ETEST Gepotidacin system regulated, and what classification does it hold?

The ETEST Gepotidacin system is classified as a Class II medical device under the FDA’s regulatory framework (product code JWY, category 866.1640). It holds both FDA 510(k) clearance (K260447) and IVDR compliance, with a determination of substantial equivalence to a predicate device. This classification reflects its role as a manual antimicrobial susceptibility test system, requiring premarket review to ensure safety and effectiveness.

What storage conditions should be followed for the ETEST Gepotidacin strips to maintain their effectiveness?

While specific storage conditions are not detailed in the provided data, standard practices for antimicrobial susceptibility test strips—such as protecting them from moisture, extreme temperatures, and direct light—are recommended. The strips should be stored in a dry environment at room temperature (typically 2–25°C) until use. Always refer to the manufacturer’s instructions for precise storage guidelines to preserve the integrity of the antibiotic gradient.

This description and any FAQs above were generated automatically from registry data and have not been verified by the manufacturer or by deviCERTS. Always check the official registry entry and the manufacturer's instructions for use before relying on them. Sources consulted: K260447 FDA 510(k) - ETEST Gepotidacin (GEP) (0.016-256 µg/mL), ETEST Gepotidacin (GEP) (0.016-256 µg/mL) (K260447) — FDA 510 (k ..., PDF 510(k) SUBSTANTIAL EQUIVALENCE DETERMINATION DECISION SUMMARY ASSAY ONLY, Product: ETEST GEPOTIDACIN GEP M100 US - 424371 - eshop.biomerieux.com

Authorization Coverage (2 countries)

Regulatory Authorizations

European Union Active

IVDR

United States Active

FDA_510K

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Manufacturer
Biomerieux Sa
FDA Applicant
bioMérieux SA

Sources (3)

  • FDA 510(k) K260447 24 fields · synced Sep 18, 2026
  • EUDAMED f271d231-8077-4dbf-bc11-b02886b61075 61 fields · synced Jul 14, 2026
  • EUDAMED b6aa502b-bbff-4c68-aafd-ad2d07f10f8a 61 fields · synced Jul 15, 2026